Francis H. Murphy
Plus aucun poste en cours
Profil
Francis H.
Murphy worked as the Chief Financial & Accounting Officer at Biopure Corp.
from 1999 to 2007.
He was also a Member at Beacon Angels Services, LLC.
Murphy holds an MBA from Boston University and an undergraduate degree from Rutgers State University of New Jersey.
Anciens postes connus de Francis H. Murphy
| Sociétés | Poste | Fin |
|---|---|---|
Biopure Corp.
 Biopure Corp. Pharmaceuticals: MajorHealth Technology Biopure Corp. developed, manufactured and marketed oxygen therapeutics, a new class of pharmaceuticals that are administered intravenously to increase oxygen transport to the body's tissues. The company used patented and proprietary technology to develop and manufacture two products: Hemopure for human use, and Oxyglobin for veterinary use. It has developed Hemopure for the treatment of patients with cardiovascular ischemia. Oxyglobin, its veterinary product treated anemia in dogs, is the only oxygen therapeutic approved by the U.S. Food and Drug Administration and the European Commission. Biopure was founded in 1984 and was headquartered in Cambridge, MA. | Directeur Financier/CFO | 10/10/2007 |
Beacon Angels Services, LLC
 Beacon Angels Services, LLC Investment ManagersFinance Beacon Angels Services LLC (Beacon Angels) is a ventures capital firm founded in 2006 by Daniel S. Von Kohorn and William F. Swiggart. The firm is headquartered in Boston, Massachusetts. | Private Equity Investor | 01/04/2011 |
Formation de Francis H. Murphy
| Boston University | Masters Business Admin |
| Rutgers State University of New Jersey | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Biopure Corp.
Biopure Corp. Pharmaceuticals: MajorHealth Technology Biopure Corp. developed, manufactured and marketed oxygen therapeutics, a new class of pharmaceuticals that are administered intravenously to increase oxygen transport to the body's tissues. The company used patented and proprietary technology to develop and manufacture two products: Hemopure for human use, and Oxyglobin for veterinary use. It has developed Hemopure for the treatment of patients with cardiovascular ischemia. Oxyglobin, its veterinary product treated anemia in dogs, is the only oxygen therapeutic approved by the U.S. Food and Drug Administration and the European Commission. Biopure was founded in 1984 and was headquartered in Cambridge, MA. | Health Technology |
Beacon Angels Services, LLC
Beacon Angels Services, LLC Investment ManagersFinance Beacon Angels Services LLC (Beacon Angels) is a ventures capital firm founded in 2006 by Daniel S. Von Kohorn and William F. Swiggart. The firm is headquartered in Boston, Massachusetts. | Finance |
